<SEC-DOCUMENT>0001102598-25-000045.txt : 20250512
<SEC-HEADER>0001102598-25-000045.hdr.sgml : 20250512
<ACCEPTANCE-DATETIME>20250512165016
ACCESSION NUMBER:		0001102598-25-000045
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250512
DATE AS OF CHANGE:		20250512

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanofi
		CENTRAL INDEX KEY:			0001121404
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				133529324
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-60069
		FILM NUMBER:		25935685

	BUSINESS ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017
		BUSINESS PHONE:		33153774400

	MAIL ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI-AVENTIS
		DATE OF NAME CHANGE:	20040826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI SYNTHELABO SA
		DATE OF NAME CHANGE:	20010104

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amundi
		CENTRAL INDEX KEY:			0001330387
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		91-93 BOULEVARD PASTEUR
		CITY:			PARIS
		STATE:			I0
		ZIP:			75015
		BUSINESS PHONE:		33 1 43 23 30 30

	MAIL ADDRESS:	
		STREET 1:		91-93 BOULEVARD PASTEUR
		CITY:			PARIS
		STATE:			I0
		ZIP:			75015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Amundi Group
		DATE OF NAME CHANGE:	20100122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Credit Agricole Asset Management Group
		DATE OF NAME CHANGE:	20060123

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Segespar
		DATE OF NAME CHANGE:	20050616
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13G/A</submissionType>
<previousAccessionNumber>0001102598-25-000017</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001330387</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>7</amendmentNo>
<securitiesClassTitle>Common Stock and American Depositary Receipts</securitiesClassTitle>
<eventDateRequiresFilingThisStatement>03/31/2025</eventDateRequiresFilingThisStatement>
<issuerInfo>
<issuerCik>0001121404</issuerCik>
<issuerName>Sanofi</issuerName>
<issuerCusip>FR0000120578</issuerCusip>
<issuerPrincipalExecutiveOfficeAddress>
<com:street1>46 AVENUE LA GRANDE ARMEE</com:street1>
<com:city>PARIS</com:city>
<com:stateOrCountry>I0</com:stateOrCountry>
<com:zipCode>75017</com:zipCode>
</issuerPrincipalExecutiveOfficeAddress>
</issuerInfo>
<designateRulesPursuantThisScheduleFiled>
<designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
</designateRulesPursuantThisScheduleFiled>
</coverPageHeader>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>AMUNDI</reportingPersonName>
<citizenshipOrOrganization>I0</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>29656486</sharedVotingPower>
<sharedDispositivePower>59281552</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>59281552</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>4.8</classPercent>
<typeOfReportingPerson>HC</typeOfReportingPerson>
<comments>Amundi does not have voting rights on 24,023,229 shares which are held through a FCPE (Fonds Commun de Placement d'Enterprise, an investment vehicle established under French law), solely dedicated to Sanofi group's employees shareholding.  Employees of Sanofi are granted the right to participate in stock purchase plans in which the shares acquired are exclusively held in this FCPE, created at the request of Sanofi.  The voting rights associated to these shares are exercised by the supervisory Board of the FCPE, where representatives of the employees have the majority (if any remaining seats of the supervisory board are designated by Sanofi), and not by Amundi.</comments>
</coverPageHeaderReportingPersonDetails>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Amundi Asset Management US, Inc.</reportingPersonName>
<citizenshipOrOrganization>I0</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<sharedVotingPower>29656486</sharedVotingPower>
<sharedDispositivePower>59281552</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>59281552</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>4.8</classPercent>
<typeOfReportingPerson>FI</typeOfReportingPerson>
<comments>Amundi does not have voting rights on 24,023,229 shares which are held through a FCPE (Fonds Commun de Placement d'Enterprise, an investment vehicle established under French law), solely dedicated to Sanofi group's employees shareholding.  Employees of Sanofi are granted the right to participate in stock purchase plans in which the shares acquired are exclusively held in this FCPE, created at the request of Sanofi.  The voting rights associated to these shares are exercised by the supervisory Board of the FCPE, where representatives of the employees have the majority (if any remaining seats of the supervisory board are designated by Sanofi), and not by Amundi.</comments>
</coverPageHeaderReportingPersonDetails>
<items>
<item1>
<issuerName>Sanofi</issuerName>
<issuerPrincipalExecutiveOfficeAddress>46 AVENUE LA GRANDE ARMEE, PARIS, France, 75017</issuerPrincipalExecutiveOfficeAddress>
</item1>
<item2>
<filingPersonName>Amundi; Amundi Asset Management</filingPersonName>
<principalBusinessOfficeOrResidenceAddress>Amundi, 91-93 boulevard Pasteur, 75015 Paris, France; Amundi Asset Management, 90 boulevard Pasteur, 75015 Paris, France</principalBusinessOfficeOrResidenceAddress>
<citizenship>Both Amundi and Amundi Asset Management are organized under the laws of the Republic of France.</citizenship>
</item2>
<item4>
<amountBeneficiallyOwned>See Item 9 of each cover page.</amountBeneficiallyOwned>
<classPercent>See Item 11 of each cover page.</classPercent>
<numberOfSharesPersonHas>
<solePowerOrDirectToVote>See Item 5 of each cover page.</solePowerOrDirectToVote>
<sharedPowerOrDirectToVote>See Item 6 of each cover page.</sharedPowerOrDirectToVote>
<solePowerOrDirectToDispose>See Item 7 of each cover page.</solePowerOrDirectToDispose>
<sharedPowerOrDirectToDispose>See Item 8 of each cover page.</sharedPowerOrDirectToDispose>
</numberOfSharesPersonHas>
</item4>
<item5>
<notApplicableFlag>N</notApplicableFlag>
<classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
</item5>
<item6>
<notApplicableFlag>Y</notApplicableFlag>
</item6>
<item7>
<notApplicableFlag>N</notApplicableFlag>
<subsidiaryIdentificationAndClassification>AMUNDI SGR&#13;
AMUNDI AM&#13;
AMUNDI AUSTRIA GMBH&#13;
AMUNDI CZECH REPUBLIC&#13;
AMUNDI DEUTSCHLAND GMBH&#13;
AMUNDI IRELAND LTD&#13;
AMUNDI JAPAN&#13;
AMUNDI ASSET MANAGEMENT US, INC.&#13;
AMUNDI SGR&#13;
BFT INVESTMENT MANAGERS&#13;
CPR&#13;
KBI GLOBAL INVESTORS LTD&#13;
S2G&#13;
SABADELL ASSET MANAGEMENT</subsidiaryIdentificationAndClassification>
</item7>
<item8>
<notApplicableFlag>Y</notApplicableFlag>
</item8>
<item9>
<notApplicableFlag>Y</notApplicableFlag>
</item9>
<item10>
<notApplicableFlag>N</notApplicableFlag>
<certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
</item10>
</items>
<signatureInformation>
<reportingPersonName>AMUNDI</reportingPersonName>
<signatureDetails>
<signature>/s/ John M. Malone</signature>
<title>John M. Malone; Chief Compliance Officer</title>
<date>05/06/2025</date>
</signatureDetails>
</signatureInformation>
<signatureInformation>
<reportingPersonName>Amundi Asset Management US, Inc.</reportingPersonName>
<signatureDetails>
<signature>/s/ John M. Malone</signature>
<title>John M. Malone; Chief Compliance Officer</title>
<date>05/06/2025</date>
</signatureDetails>
</signatureInformation>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
